Buy & Sell Sirius XM Holdings Inc (SIRI) – Sirius XM Holdings Inc Price Today
Aura AI Summary
Key Stats
- $9.09BMarket Cap
- MediaSector
- -9.57%3M Drawdown
- $18.76BEnterprise Value
- 4%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 90 daysTypical Hold Time
Sirius XM Holdings Inc (SIRI) is currently valued at a market capitalization of $9.09B, with an enterprise value of $18.76B. Over the past 52 weeks, Sirius XM Holdings Inc has traded between a low of $19.92 and a high of $29.87, highlighting its annual price range. Over the past three months, Sirius XM Holdings Inc has recorded a drawdown of -9.57%, reflecting recent price volatility. Sirius XM Holdings Inc offers a dividend yield of 4%, with the most recent dividend of $0.27 paid on 11 May 26. On average, investors hold Sirius XM Holdings Inc for approximately 90 days, indicating typical investor behavior on the platform.
About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Most Recent News
Tesla's robotaxi fleet shrinks amid safety concerns; SpaceX IPO filing hints at major equity moves.
Tesla has reduced its robotaxi fleet to about 20 vehicles despite expanding the Austin service area, raising safety concerns from former engineers. Meanwhile, SpaceX updated its IPO filing, indicating a lock-in period for Musk's shares and potential ...

AI boom drives strong earnings beats, policy debates, and major tech moves worldwide
Recent financial reports show strong earnings beats driven by surging demand for artificial intelligence (AI) technologies, with companies like ServiceTitan, Palo Alto Networks, and CrowdStrike exceeding revenue and earnings estimates. Policymakers i...

Foundayo leads to significant weight loss in menopausal women, including those with type 2 diabetes, in clinical trials.
Eli Lilly's Foundayo (orforglipron) showed significant weight loss results in women across all menopause stages in the ATTAIN-1 and ATTAIN-2 trials, including those with type 2 diabetes. Women lost up to 30.4 lbs (14.4%) in perimenopause and up to 28...
